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Unsuitable blood glucose measuring de-
vices in neonatal or paediatric acute care
To the Editor: In acute neonatal or paediatric care, bedside 
blood glucose measurement is aimed predominantly at 
identifying hypoglycaemia, but high readings prompt the 
suspicion of diabetes mellitus or the stress hyperglycaemia 
of critical illness, in which high blood glucose levels correlate 
positively with poorer outcome.1  
A recent case has reminded us that bedside glucose testing is 
not always specific for glucose only.2 
A 13-day-old girl presented with persistent neonatal 
jaundice, profound micro-angiopathic haemolytic anaemia, 
a grossly prolonged prothrombin time and a white cell 
leukaemoid reaction of 53×109/l. Escherichia coli was cultured 
from the urine, and the patient responded to antibiotics. 
Blood glucose monitoring with Accu-chek glucose meter 
(Roche Diagnostics) test strips gave persistently high readings. 
The absence of glycosuria and a comparison with laboratory 
blood glucose values alerted us to the fact that the readings 
were falsely elevated. This was due to a high blood galactose 
level in this patient, in whom the diagnosis of galactosaemia 
due to transferase deficiency was subsequently confirmed. 
We had failed to appreciate the fact that the glucose dye 
oxidoreductase mediator reaction (glucose dehydrogenase) as 
used in the Roche Accu-chek also measures galactose.3
Previously, in a comparison of point-of-care glucose 
meters Newman et al.4 had found the Roche Accu-chek to 
give equimolar interference of galactose with glucose and 
therefore to risk gross overestimation of glucose in cases of 
galactosaemia. 
A normal blood galactose level  (<0.44 mmol/l5) is not 
high enough to result in clinically significant elevation of 
the combined blood glucose and galactose level. However, 
permanent or transient elevation of blood galactose is found 
in galactosaemia, liver dysfunction or maturational delay 
of galactose transport or utilisation,5 and then can indeed 
affect measurements and clinical judgement. The present case 
illustrates this risk to the detriment of the patient.
We conclude that the Accu-chek glucose meter is not suitable 
as a blood glucose measuring device in neonatal or paediatric 
intensive care units wherever elevation of blood galactose 
levels cannot be excluded a priori, and should be removed from 
routine use in such areas.
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Information for patients
To the Editor: Most patients crave information concerning 
their illnesses and the interventions planned for their 
treatment. Most doctors are too busy to be able to give 
patients the additional time necessary to impart this and to 
encourage the patient to ask questions. My experience as the 
National Medical Ombudsman confirmed how important 
communication was in preventing subsequent problems. 
Furthermore, the law requires that for consent for a procedure 
to be valid, the patient must be fully informed – this is hardly 
ever done.
For all these reasons I would urge the various societies, 
specialist and general practice, to prepare relevant ‘hand-outs’
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for their patients, spelling out what is the matter with them, 
what, if anything, caused the problem, what is proposed to be 
done, what the possible complications are (with incidences) 
and how the post-intervention period is likely to run.
I anticipate that one objection to this suggestion will be 
that every patient is unique and that generalisations cannot 
therefore be made; another that every doctor is different and 
has different approaches to problems. I would counter these 
objections, firstly by claiming that there are many routine 
procedures in every branch of medicine and that it is in fact 
possible to make broad generalisations, which, if necessary, 
can be modified for individual patients. Secondly, the societies 
could put out generalised ‘hand-outs’ in digital form which 
could than be modified by the individual practitioners.
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WEB-BASED CPD short courses 
 in PHARMACOLOGICAL 
 Principles of DRUG THERAPY (distance learning) 
– may lead to an Hons B Sc degree in Pharmacology
Enrol throughout the year
This unique Internet and Web-assisted learning programme has been devel oped 
by the School of Pharmacy (Faculty of Health Sciences) to give medical practitioners 
a general insight into the basic pharmacological and ethical prin ciples on which 
therapeutic strategies are based, enabling them to practise more effective pharma-
cotherapy in community medicine. 
Enrol for the whole programme or selected modules only.
Who should enrol?
• Medical Practitioners and Specialists
• Pharmacists
Why enrol?
• Continued Professional Development (CPD) 
• Stay abreast with the latest trends in Pharmacology
• Empowerment for career development
Candidates can either enrol for the degree programme or specific 
module(s) as certificate course(s).
Some of the certificate courses on offer for you:
• Drugs and the Peripheral Nervous System
• Drugs and the Central Nervous System
• Drugs and the Renal and Cardiovascular Systems
• Drugs for Pain, Inflammation, Fever and Airways Disease 
• Chemotherapy of Infections and Infestations
• Hormones, Hormonoids and Hormone Antagonists Drugs 
for GIT and Skin
• Vitamins, Haematopoietics and Immunopharmacology
• Advanced Pharmacological Principles
• Evidence-Based Medicine
Please visit our website at: 
www.nwu.ac.za/webpharmacol for more information 
or contact: Alsorika Kraukamp  
Tel: +27(0)18 299 2260 Fax: +27(0)18 299 4244
E-mail: alsorika.kraukamp@nwu.ac.za
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